Summary
The activities of hepatic and lipoprotein lipase and the levels of lipo- and apoproteins were compared in two groups of normoglycaemic men representing the highest (n=18) and lowest (n=15) fasting insulin quintiles of first degree male relatives of non-insulin-dependent diabetic patients. The high insulin group representing insulin-resistant individuals had significantly lower post-heparin plasma lipoprotein lipase activity than the low insulin group (14.2±4.0 vs 20±5.8 Μmol NEFA·ml−1·h−1, p<0.001); hepatic lipase activity did not differ between the two groups (24.2±11 vs 18.0±5.3 Μmol NEFA·ml−1·h−1, NS). The lipoprotein lipase/hepatic lipase ratio in the high insulin group was decreased by 66% as compared to the low insulin group (0.75±0.57 vs 1.25±0.65, p<0.01). In the high insulin group both total and VLDL triglycerides were higher than in the low insulin group (1.61±0.57 vs 0.86±0.26 mmol/l, p< 0.001 and 1.00±0.47 vs 0.36±0.16 mmol/l, p<0.001, respectively) whereas HDL cholesterol and HDL2 cholesterol were lower (1.20±0.30 vs 1.43±0.22 mmol/l, p<0.05 and 0.49±0.21 vs 0.71±0.17 mmol/l, p<0.05, respectively). Total cholesterol, LDL cholesterol or HDL3 cholesterol did not differ between the two groups. The mean particle size of LDL was smaller in the high insulin group than in the low insulin group (258±7 vs 265±6 å, p<0.05). We propose that the changes of lipoprotein lipase and lipoprotein lipase/hepatic lipase ratio cluster with insulin resistance and provide a possible mechanism to explain the lowering of HDL cholesterol and elevation of triglyceride concentrations observed in insulin-resistant subjects.
Article PDF
Similar content being viewed by others
Abbreviations
- LPL:
-
Lipoprotein lipase
- HL:
-
hepatic lipase
- VLDL:
-
very low density lipoprotein
- IDL:
-
intermediate density lipoprotein
- LDL:
-
low density lipoprotein
- HDL:
-
high density lipoprotein
- chol:
-
cholesterol
- TG:
-
triglycerides
- NEFA:
-
non-esterified fatty acids
References
Reaven GM (1988) Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37: 1595–1607
DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194
Haffner SM, Valdez RA, Hazuda HP, Braxton DM, Morales PA, Stern MP (1992) Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41: 715–722
Selby JV, Austin MA, Newman B et al. (1993) LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88: 381–387
Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM (1993) Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 92: 141–146
Austin MA, King M-C, Vranizan KM, Krauss (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82: 495–506
Campos H, Genest JJ Jr, Blijlevens E et al. (1992) Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis 12: 187–195
Reaven GM, Lerner RL, Stern MP, Farquhar JW (1967) Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46: 1756–1767
Orchard T, Becker DJ, Bates M, Kuller LH, Drash AL (1983) Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118: 326–337
Abbot WGH, Lillioja S, Young AA et al. (1987) Relationship between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 36: 897–904
MykkÄnen L, Kuusisto J, PyörÄlÄ K, Laakso M (1993) Cardiovascular disease factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36: 553–559
Garg A, Heldermann JH, Koffler M, Ayosos R, Rosenstock J (1988) Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37: 982–987
Yki-JÄrvinen H, Taskinen M-R (1988) Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes 37: 1271–1278
Taskinen M-R (1990) Hyperlipidemia in diabetes. Baill Clin Endocrinol Metab 4: 743–775
Sparks JD, Sparks CE (1990) Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem 265: 8854–8862
Gibbons GF (1990) Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 268: 1–13
Frayn KN (1993) Insulin resistance and lipid metabolism. Curr Opinion Lipidol 4: 197–204
Lewis GF, Uffelman KD, Szeto LW, Steiner G (1993) Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 42: 833–842
PykÄlistö OJ, Smith PH, Brunzell JD (1975) Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. J Clin Invest 56: 1108–1117
Ong JM, Kern PA (1989) Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein and messenger RNA levels in human adipose tissue. J Clin Invest 84: 305–311
Eckel RH (1989) Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320: 1060–1068
Coppack SW, Evans RD, Fisher RM et al. (1992) Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41: 264–272
Pollare T, Vessby B, Lithell H (1991) Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arteriosclerosis 11: 1192–1203
Taskinen M-R, Kuusi T (1987) Enzymes involved in triglyceride hydrolysis. Baill Clin Endocrinol Metab 1: 639–666
Harno K, NikkilÄ EA, Kuusi T (1980) Plasma HDL-cholesterol and postheparin plasma hepatic endothelial lipase (HL) activity: relationship to obesity and non-insulin dependent diabetes (NIDDM). Diabetologia 19: 281 (Abstract)
Kasim SE, Kingston T, Jen K-LC, Khilnani S (1987) Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus. J Clin Endocrinol Metab 65: 183–187
Baynes C, Henderson AD, Anyaoku V et al. (1991) The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes. Diabet Med 8: 560–566
Blades B, Vega GL, Grundy SM (1993) Activities of lipoprotein lipase and hepatic lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arteriosclerosis 13: 1227–1235
Lamarche B, Despres J-P, Pouliot M-C et al. (1993) Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arteriosclerosis 13: 33–40
Laws A, Stefanick L, Reaven GM (1989) Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin dependent diabetes mellitus. J Clin Endocrinol Metab 69: 343–347
Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337–343
Gulli G, Ferrannini E, Stern E, Haffner S, DeFronzo RA (1992) The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41: 1575–1586
Laakso M (1993) How good a marker is insulin level for insulin resistance? Am J Epidemiol 137: 959–965
Sarlund H, PyörÄlÄ K, PenttilÄ I, Laakso M (1992) Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes. Arteriosclerosis 12: 657–663
World Health Organization (1985) Diabetes mellitus. Report of a WHO Study Group, Geneva. Technical Report Series no. 727
Havel RJ, Eder HA, Brigdon JH (1956) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
Taskinen M-R, Kuusi T, Helve E, NikkilÄ EA, Yki-JÄrvinen H (1988) Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 8: 168–177
Huttunen JK, Ehnholm CJ, Kinnunen PKJ, NikkilÄ EA (1975) An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta 63: 335–347
Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC (1990) Differential electroimmunoassay of human LpA-I lipoprotein particles on ready to-use plates. Clin Chem 36: 1431–1435
Kahri J, Groop P-H, Viberti G, Elliott T, Taskinen M-R (1993) Regulation of apolipoprotein A-I- containing lipoproteins in IDDM. Diabetes 42: 1281–1288
Nichols AV, Krauss RM, Musliner TA (1986) Nondenaturating polyacrylamide gradient gel electrophoresis. In: Segrest JP, Albers JJ (eds) Methods in enzymology: Plasma lipoproteins (vol 128). Academic Press, London, pp 417–431
Margolis J, Kenrick KG (1967) Electrophoresis in polyacrylamide concentration gradient. Biochem Biophys Res Comm 27: 68–73
Polyacrylamide gel electrophoresis 1984 Laboratory techniques. Pharmacia, Laboratory separation division, Uppsala, Sweden, pp 16–20
Tilly-Kiesi M, SyvÄnne M, Kuusi T, LahdenperÄ S, Taskinen M-R (1992) Abnormalities of low density lipoproteins in normolipidemic type 2 diabetic and non-diabetic patients with coronary artery disease. J Lipid Res 33: 333–342
Kern PA, Ong JM, Saffari B, Carty J (1990) The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans. N Engl J Med 322: 1053–1059
Taylor KG, Dalton DJ, Holdsworth G (1979) Insulin-independent diabetes: a defect in the activity of lipoprotein lipase in adipose tissue. Diabetologia 16: 313–317
Sadur CN, Yost TJ, Eckel RH (1984) Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but present in obesity. J Clin Endocrinol Metab 59: 1176–1182
Taskinen M-R (1987) Lipoprotein lipase in hypertriglyceridemias. In: Borensztajn J (ed): Lipoprotein lipase. Evener Publishers, Inc. Chicago, pp 201–228
Peterson J, Bihain BE, Bengtsson-Olivecrona G, Deckelbaum RJ, Carpentier YA, Olivecrona T (1990) Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci U.S.A. 87: 909–913
Saxena U, Goldberg IJ (1990) Interaction of lipoprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. Biochim Biophys Acta 1043: 161–168
Golay A, Chen YD, Reaven GM (1986) Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab 62: 1081–1088
Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, De Fronzo RA (1991) The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72: 96–107
Coppack SW, Jensen MD, Miles JM (1994) In vivo regulation of lipolysis in humans. J Lipid Res 35: 177–193
Miesenböck G, Hölzl B, Föger B et al. (1993) Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 91: 448–455
Brinton EA, Eisenberg S, Breslow J (1994) Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arterioscler Thromb 14: 707–720
James RW, Pometta D (1990) Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. Atherosclerosis 83: 35–45
Montali A, Vega GL, Grundy SM (1994) Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia. Arteriosclerosis 14: 511–517
Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S (1984) Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4: 225–231
Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P (1993) Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arteriosclerosis 13: 815–825
Patsch JR, Prasad S, Gotto AM Jr, Patsch W (1987) High density Iipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80: 341–347
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Knudsen, P., Eriksson, J., LahdenperÄ, S. et al. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Diabetologia 38, 344–350 (1995). https://doi.org/10.1007/BF00400640
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400640